{
  "ptid_time": "052_S_4959_2013-03-04",
  "img_path": "/data/qiuhui/data/adni/images/052_S_4959/2013-03-04/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 61,068 mm³, 58.5% above the reference mean. With a Z-score of 1.40 (92.0th percentile), this represents mild enlargement; hippocampal volume measures 7,381 mm³, 2.4% below the reference mean. With a Z-score of -0.23 (40.9th percentile), this represents normal volume ; whole brain volume measures 1,190,010 mm³, 10.2% above the reference mean. With a Z-score of 1.33 (90.8th percentile), this represents mild enlargement; entorhinal cortex volume measures 3,969 mm³, 3.2% below the reference mean. With a Z-score of -0.22 (41.4th percentile), this represents normal volume ; fusiform gyrus volume measures 19,499 mm³, 3.5% above the reference mean. With a Z-score of 0.30 (61.7th percentile), this represents normal volume ; middle temporal gyrus volume measures 23,668 mm³, 10.9% above the reference mean. With a Z-score of 0.98 (83.7th percentile), this represents normal volume . ",
  "text_data": "Age is 77.5 years. Gender is Male. Education: 20 years. Handedness: Right. Race: White. Medical history: Cardiovascular; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 25.0. MoCA: 23.0. Logical Memory: 0.0. Laboratory findings: MCHC: 36.00 (significant elevated); Serum Glucose: 153.00 (profound elevated); Creatine Kinase: 220.00 (significant elevated). APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.52 SUVR (profound elevated); Amyloid beta: 349.80 pg/mL (moderate reduced); Total tau: 178.90 pg/mL (normal ); Phosphorylated tau: 19.02 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The ventricular volume is mildly enlarged (58.5% above mean, Z=1.40), suggesting possible atrophy, while hippocampal and entorhinal cortex volumes are within normal limits. Aβ is moderately reduced, and AV45 (amyloid PET) is profoundly elevated, indicating significant amyloid pathology. Cognitive scores (MMSE 25, MoCA 23) are borderline but not severely impaired.  \n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amyloid-positive, early neurodegenerative changes).  \n**Confidence:** **Medium** (cognitive scores are near the MCI/dementia threshold, but structural atrophy is not yet severe).  \n\n*Note: The elevated AV45 and reduced Aβ strongly suggest Alzheimer’s pathology, but the lack of severe atrophy or marked cognitive decline makes dementia less likely at this stage.*",
  "timestamp": "2025-07-26T07:52:20.887114"
}